-transparent.png){kind=logo}
Cell lysates and exocytosed soluble mediator(s) (ESM) released from CD8+ T cell lines (TCL) by receptor-triggered secretory exocytosis were tested for degradation of proteoglycans associated with in vitro produced subendothelial extracellular matrix (ECM). ESM was found to release low-molecular weight (kav 0.5-0.6) fragments from the sulfated proteoglycans in ECM. In the presence of heparin, an inhibitor for endoglycosidase activity, only high-molecular-weight products (kav 0.2) were formed. Preincubation of ESM with HD-prolylphenylalanyl-arginyl-chloromethylketone (PFR-CK) an inhibitor for the T cell-associated serine proteinase-1 (MTSP-1) totally prevented release of high- and low-molecular weight proteoglycan fragments. Furthermore, it was shown that purified MTSP-1 is able to release from ECM high-molecular weight proteoglycans and that this process is inhibitable by PFR-CK but not by heparin. Further treatment of these soluble high-molecular weight sulfated proteoglycans with ESM from TCL 1.D9 led to appearance of low-molecular weight split products (kav 0.5-0.6). This conversion was inhibitable by heparin but not by PFR-CK. These findings indicate that activated T cells contain two enzymatic activities, i.e. MTSP-1 and at least one endoglycosidase, which after receptor-triggered secretion can synergize in the degradation of sulfated proteoglycans in subendothelial ECM.
U Vettel, and
R Bar-Shavit, and
M M Simon, and
G Brunner, and
I Vlodavsky, and
M D Kramer
May 1990,
Biological chemistry Hoppe-Seyler,
U Vettel, and
R Bar-Shavit, and
M M Simon, and
G Brunner, and
I Vlodavsky, and
M D Kramer
May 1989,
Biochemical and biophysical research communications,
U Vettel, and
R Bar-Shavit, and
M M Simon, and
G Brunner, and
I Vlodavsky, and
M D Kramer
January 1988,
Advances in experimental medicine and biology,
U Vettel, and
R Bar-Shavit, and
M M Simon, and
G Brunner, and
I Vlodavsky, and
M D Kramer
January 1990,
FEBS letters,
U Vettel, and
R Bar-Shavit, and
M M Simon, and
G Brunner, and
I Vlodavsky, and
M D Kramer
December 2000,
The Journal of biological chemistry,
U Vettel, and
R Bar-Shavit, and
M M Simon, and
G Brunner, and
I Vlodavsky, and
M D Kramer
May 1987,
European journal of immunology,
U Vettel, and
R Bar-Shavit, and
M M Simon, and
G Brunner, and
I Vlodavsky, and
M D Kramer
June 1988,
European journal of immunology,
U Vettel, and
R Bar-Shavit, and
M M Simon, and
G Brunner, and
I Vlodavsky, and
M D Kramer
January 1991,
International immunology,
U Vettel, and
R Bar-Shavit, and
M M Simon, and
G Brunner, and
I Vlodavsky, and
M D Kramer
May 1988,
European journal of immunology,
U Vettel, and
R Bar-Shavit, and
M M Simon, and
G Brunner, and
I Vlodavsky, and
M D Kramer
December 2009,
Medical oncology (Northwood, London, England),
